Brought to you by 
Jones buys Daniels, strengthening position in thyroid drugs
13 Jul 1999
Executive Summary
Jones Medical (specialty pharmaceuticals manufacturer) signed a definitive agreement to acquire all outstanding shares of Daniels Pharmaceuticals (makes Levoxyl thyroid hormone and other prescription drugs) for 3mm common shares worth about $100mm.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Jones buys Daniels, strengthening position in thyroid drugs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice